These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9129052)

  • 41. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification.
    Zhang F; Tetali S; Wang XP; Kaplan MH; Cromme FV; Ginocchio CC
    J Clin Microbiol; 2000 May; 38(5):1920-5. PubMed ID: 10790122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages.
    Coffey MJ; Woffendin C; Phare SM; Strieter RM; Markovitz DM
    Am J Physiol; 1997 May; 272(5 Pt 1):L1025-9. PubMed ID: 9176270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1.
    Semenzato G; Agostini C; Ometto L; Zambello R; Trentin L; Chieco-Bianchi L; De Rossi A
    Blood; 1995 May; 85(9):2308-14. PubMed ID: 7727764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colocalisation of human immunodeficiency virus and human cytomegalovirus infection in brain autopsy tissue from AIDS patients.
    Balluz IM; Farrell MA; Kay E; Staunton MJ; Keating JN; Sheils O; Cosby SL; Mabruk MJ; Sheahan BJ; Atkins GJ
    Ir J Med Sci; 1996; 165(2):133-8. PubMed ID: 8698561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.
    Poli G; Kinter AL; Justement JS; Bressler P; Kehrl JH; Fauci AS
    J Exp Med; 1991 Mar; 173(3):589-97. PubMed ID: 1705278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro.
    Meyer AL; Bruening EE; Dunkle WE; Booth RJ; Steinbaugh BA; Vara Prasad JV
    Antiviral Res; 2001 Dec; 52(3):289-300. PubMed ID: 11675146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages.
    Kootstra NA; van 't Wout A; Huisman HG; Miedema F; Schuitemaker H
    J Virol; 1994 Nov; 68(11):6967-75. PubMed ID: 7933078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
    Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
    J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of tumor necrosis factor-alpha and interleukin-1 by alveolar macrophages from HIV-1-infected persons.
    Cox RA; Anders GT; Cappelli PJ; Johnson JE; Blanton HM; Seaworth BJ; Treasure RL
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):431-41. PubMed ID: 2340204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.
    Montaner LJ; Doyle AG; Collin M; Herbein G; Illei P; James W; Minty A; Caput D; Ferrara P; Gordon S
    J Exp Med; 1993 Aug; 178(2):743-7. PubMed ID: 8101865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive Analysis of Human Cytomegalovirus- and HIV-Mediated Plasma Membrane Remodeling in Macrophages.
    Businger R; Kivimäki S; Simeonov S; Vavouras Syrigos G; Pohlmann J; Bolz M; Müller P; Codrea MC; Templin C; Messerle M; Hamprecht K; Schäffer TE; Nahnsen S; Schindler M
    mBio; 2021 Aug; 12(4):e0177021. PubMed ID: 34399625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.
    Peterson PK; Gekker G; Chao CC; Hu SX; Edelman C; Balfour HH; Verhoef J
    J Clin Invest; 1992 Feb; 89(2):574-80. PubMed ID: 1310698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages.
    Wahl SM; Greenwell-Wild T; Peng G; Hale-Donze H; Orenstein JM
    J Infect Dis; 1999 May; 179 Suppl 3():S457-60. PubMed ID: 10099119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage.
    Saville MW; Taga K; Foli A; Broder S; Tosato G; Yarchoan R
    Blood; 1994 Jun; 83(12):3591-9. PubMed ID: 7911340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
    Emery VC; Sabin C; Feinberg JE; Grywacz M; Knight S; Griffiths PD
    J Infect Dis; 1999 Sep; 180(3):695-701. PubMed ID: 10438356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human cytomegalovirus replication by tricin is associated with depressed CCL2 expression.
    Akai Y; Sadanari H; Takemoto M; Uchide N; Daikoku T; Mukaida N; Murayama T
    Antiviral Res; 2017 Dec; 148():15-19. PubMed ID: 28965916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection.
    King CA; Baillie J; Sinclair JH
    J Gen Virol; 2006 Aug; 87(Pt 8):2171-2180. PubMed ID: 16847113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional antibody response to human cytomegalovirus in immunocompetent and HIV-1 infected individuals with antibodies that inhibit virus penetration into cells and intercellular transmission of viral infection.
    Alberola J; Tamarit A; Navarro D
    J Med Microbiol; 1999 Oct; 48(10):947-954. PubMed ID: 10510972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions.
    Sadat-Sowti B; Parrot A; Quint L; Mayaud C; Debre P; Autran B
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):972-80. PubMed ID: 7511468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.